Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alissa Visram

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|May 19, 2023
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapyMarisa K Kilgour, Donald J Bastin, Seung-Hwan Lee, et al.
Plos One|April 16, 2015
Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screeningAlissa Visram, Kelvin K W Chan, Phyllis McGee, et al.
Cancers|February 13, 2025
A Prognostic Symptom Model Incorporating Patient-Reported Symptoms for Transplant-Ineligible Patients with Multiple MyelomaAmaris K Balitsky, Rinku Sutradhar, Hsien Seow, et al.
Blood Advances|December 18, 2025
Real world comparison of progression free survival and time to next therapy in 761 newly diagnosed multiple myeloma patientsHira Mian, Mariano Arribas, Rafael Fonseca, et al.
Blood Advances|February 24, 2026
Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myelomaHira Mian, Mariano Arribas, Rafael Fonseca, et al.
Cytotherapy|July 9, 2025
CAR-NK cells to treat patients with cancer: a systematic scoping review of published studies and registered clinical trialsSimrit Rana, Lilli Thomas, Aidan M Kirkham, et al.
Research Square|February 7, 2023
An atlas of the bone marrow bone proteome in patients with dysproteinemiasMatthew Ho, Surendra Dasari, Alissa Visram, et al.
American Journal of Hematology|May 16, 2023
Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population-based cohort studyAlissa Visram, Hsien Seow, Mark A Fiala, et al.
Blood Cancer Journal|October 16, 2024
Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort studyGhulam Rehman Mohyuddin, Hira Mian, Anastasia Gayowsky, et al.
Blood|October 22, 2024
Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detectionAlissa Visram, Dirk Larson, Aaron Norman, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|May 19, 2023
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapyMarisa K Kilgour, Donald J Bastin, Seung-Hwan Lee, et al.
Plos One|April 16, 2015
Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screeningAlissa Visram, Kelvin K W Chan, Phyllis McGee, et al.
Cancers|February 13, 2025
A Prognostic Symptom Model Incorporating Patient-Reported Symptoms for Transplant-Ineligible Patients with Multiple MyelomaAmaris K Balitsky, Rinku Sutradhar, Hsien Seow, et al.
Blood Advances|December 18, 2025
Real world comparison of progression free survival and time to next therapy in 761 newly diagnosed multiple myeloma patientsHira Mian, Mariano Arribas, Rafael Fonseca, et al.
Blood Advances|February 24, 2026
Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myelomaHira Mian, Mariano Arribas, Rafael Fonseca, et al.
Cytotherapy|July 9, 2025
CAR-NK cells to treat patients with cancer: a systematic scoping review of published studies and registered clinical trialsSimrit Rana, Lilli Thomas, Aidan M Kirkham, et al.
Research Square|February 7, 2023
An atlas of the bone marrow bone proteome in patients with dysproteinemiasMatthew Ho, Surendra Dasari, Alissa Visram, et al.
American Journal of Hematology|May 16, 2023
Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population-based cohort studyAlissa Visram, Hsien Seow, Mark A Fiala, et al.
Blood Cancer Journal|October 16, 2024
Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort studyGhulam Rehman Mohyuddin, Hira Mian, Anastasia Gayowsky, et al.
Blood|October 22, 2024
Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detectionAlissa Visram, Dirk Larson, Aaron Norman, et al.
Pageof 8